Last checked at 11 Mar 2022 11:23
Kanabo Group Plc
("Kanabo" or the "Company")
Investor Updates
Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company focussing on the development and distribution of cannabis-derived products for medical patients and wellness CBD consumers, has posted their latest investor newsletter and investor presentation to their website.
The latest Company presentation can be viewed here;
https://www.kanabogroup.com/wp-content/uploads/2022/03/Kanabo_GP_V01_230222.pdf
The Company has also posted a recent webinar with Vox Markets where Kanabo CEO, Avihu Tamir and GP Service CEO, Atul Devani discuss the GP Services acquisition. The webinar can be viewed here;
Watch the Kanabo webinar hosted by Vox Markets - Vox Markets
The latest Kanabo Investor Newsletter discussing the significant progress made over recent months can be viewed here; https://www.kanabogroup.com/press/foreword-from-the-ceo-march-11-2002/
For further information, please visit http://www.kanabogroup.com/ or contact the following:
Kanabo Group Plc |
|
Avihu Tamir, CEO | Via Vox Markets |
Peterhouse Capital Ltd |
|
Eran Zucker (Financial Adviser) | Tel: +44 (0)20 7469 0930 |
Lucy Williams / Charles Goodfellow (Corporate Broker) | Tel: +44 (0)20 7469 0930 |
Vox Markets (Investor Relations) |
|
Kat Perez | KanaboGroup@voxmarkets.co.uk |
About Kanabo Group Plc
Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers. It has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.